Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad D Bala

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
cis-N-(2-Hydroxy-cyclo-hexyl)-p-toluene-sulfonamideMohamed I Fadlalla, Holger B Friedrich, Glenn E M Maguire, et al.
Iucrdata|January 8, 2025
3-(2-Hy-droxy-eth-yl)-1-(4-nitro-phen-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-3-ium bromideHalliru Ibrahim, Sizwe J Zamisa, Muhammad D Bala, et al.
Medicinal Research Reviews|February 7, 2025
The Emerging Landscape of Tubercular Targets: A Medicinal Chemistry ApproachBaji Baba Shaik, Kimeshni Moodley, Safiyah Ghumran, et al.
Molecules (Basel, Switzerland)|March 13, 2024
Chemotherapeutic Activities of New η<sup>6</sup>-<i>p</i>-Cymene Ruthenium(II) and Osmium(II) Complexes with Chelating SS and Tridentate SNS LigandsDavid O Ywaya, Halliru Ibrahim, Holger B Friedrich, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 20, 2022
Recent Literature Review on Coumarin Hybrids as Potential Anticancer AgentsBaji Baba Shaik, Naresh Kumar Katari, Pule Seboletswe, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Acta Crystallographica. Section E, Structure Reports Online|May 18, 2011
cis-N-(2-Hydroxy-cyclo-hexyl)-p-toluene-sulfonamideMohamed I Fadlalla, Holger B Friedrich, Glenn E M Maguire, et al.
Iucrdata|January 8, 2025
3-(2-Hy-droxy-eth-yl)-1-(4-nitro-phen-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-3-ium bromideHalliru Ibrahim, Sizwe J Zamisa, Muhammad D Bala, et al.
Medicinal Research Reviews|February 7, 2025
The Emerging Landscape of Tubercular Targets: A Medicinal Chemistry ApproachBaji Baba Shaik, Kimeshni Moodley, Safiyah Ghumran, et al.
Molecules (Basel, Switzerland)|March 13, 2024
Chemotherapeutic Activities of New η<sup>6</sup>-<i>p</i>-Cymene Ruthenium(II) and Osmium(II) Complexes with Chelating SS and Tridentate SNS LigandsDavid O Ywaya, Halliru Ibrahim, Holger B Friedrich, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 20, 2022
Recent Literature Review on Coumarin Hybrids as Potential Anticancer AgentsBaji Baba Shaik, Naresh Kumar Katari, Pule Seboletswe, et al.
Pageof 4